Request Deal Involvement

Asahi Kasei Group to acquire Veloxis for $1.3bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Guggenheim Partners

financial advisors

Guggenheim Partners

Goldman Sachs

financial advisors

Goldman Sachs

Bech-Bruun

legal advisors

Bech-Bruun

K&L Gates

legal advisors

K&L Gates

Ulveman & Borsting

pr advisors

Ulveman & Borsting

Plesner

legal advisors

Plesner

MTS Health Partners

financial advisors

MTS Health Partners

Gorrissen Federspiel

legal advisors

Gorrissen Federspiel

Accura Advokatpartnerselskab

legal advisors

Accura Advokatpartnerselskab

Gibson Dunn & Crutcher

legal advisors to financial advisors

Gibson Dunn & Crutcher

or

Principals

LUNDBECKFOND INVEST

vendor

LUNDBECKFOND INVEST

ASAHI KASEI CORPORATION

bidder

ASAHI KASEI CORPORATION

VELOXIS PHARMACEUTICALS

target

VELOXIS PHARMACEUTICALS

NOVO HOLDINGS A/S

vendor

NOVO HOLDINGS A/S

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Asahi Kasei Group to acquire Veloxis for $1.3bn.